1Malik U, Oleksowicz L, Latov N, Cardo LJ. Intravenous τ-globulin inhibits binding of anti-GM1 to its target antigen[J]. Ann Neurol, 1996; 39: 136.
2Diegel M, Rank.in B, Bolen J, Dubois P. Cross linking of Fc receptor to surface immunoglobulin on B cells provides an inhibitory signal that closes the plasma membrane calcium channel[J]. J Biol Chem,1994;269:11409.
3Ghetic V, Ward ES. FcRn: the MHC Class I-related receptor that is more than an IgG transporter[J]. Immunol Today, 1997; 18: 592.
4Suman Kumari, Kailash C.Bhol, Farah Rehman, et al. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulins therapy [J]. CYTOKINE,2001:218-224.
5Ankrust P, Muller F, Svenson M, et al, Administration of intravenous immunoglobulin(IVIG) in vivo down-regulatory effects on the IL-1 system [J]. Clin Exp hranunol,1999;115:136.
6Kekow J, Reinhold D, Pap T, Ansorge S. Intravenous immunoglobulins and transforming growth factorβ [J], Lancet,1998;351: 184.
7Kieseier BC, K.iefer R, Clements JM, et al, Matrix metalloprotcinase-9 and L 7 are regulated in experimental autoirmnune encephalomyelitis[J]. Brain, 1998; 121: 159.
8Kieseier BC, Tani M, Mahad D. et al. Chemokines and chemokine receptors in inflammatory demyelinaring neuropathies:a central role for IP-10[J]. Brain,2002;125:823.
9A.Creange, N.A.Gregson, R.A.C.Hughes. Intravenous immunoglobulin inodulates lymphocyte CD54 and monocyte FCτR Ⅱ expression in patient with chronic inflammatory neuropathies[J]. Journal of Neuroiimnunology, 2003; 135:91.
10Martin Stangel, Alastair Compston, Neil J.Scolding.Oligodendroglia are protected fi'om antibody-mediated complement injury by normal immunoglobulins("IVIG")[J], Journal of the Neuroimmunology, 2000; 103: 195.
5[3]Tan KH,Purcall WM,Heales SJ,et al.Evaluation of the role of p-glycoprotein in inflammation induced blood-brain barrier damage[J].Neuroreport,2002,13(18):2593-2597.
